# Antiaggregation in Primary Prevention of Vascular Access for Hemodialysis

> **NCT02055131** · PHASE4 · UNKNOWN · sponsor: **Tunis University** · enrollment: 300 (estimated)

## Conditions studied

- Thrombosis

## Interventions

- **DRUG:** aspirin

## Key facts

- **NCT ID:** NCT02055131
- **Lead sponsor:** Tunis University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-11
- **Primary completion:** 2014-09
- **Final completion:** 2015-03
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2014-02-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02055131

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02055131, "Antiaggregation in Primary Prevention of Vascular Access for Hemodialysis". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT02055131. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*